Technology
Scientific Publications
Peer-reviewed research supporting LUT-014 and the science of paradoxical MAPK activation by topical B-RAF inhibitors.
Featured Focus
Acneiform Rash
Topical B-RAF inhibition to mitigate papulopustular eruptions caused by EGFR and MAPK pathway inhibitors.
Lutris Publication
Reducing skin toxicities from EGFR inhibitors with topical B-RAF inhibitor therapy
Cancer Discovery·2021
Related Publication
B-RAF Inhibitors for the Treatment of Papulopustular Eruptions from MAPK Pathway Inhibitors
American Journal of Clinical Dermatology·2020
Related Publication
Pilot Trial of Combined B-RAF and EGFR Inhibition in B-RAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research·2015
Research Area
Wound Healing
Paradoxical MAPK activation by B-RAF inhibitors as a driver of cutaneous wound healing.
Research Area
Radiation Dermatitis
Clinical evidence for topical LUT-014 in the treatment of radiation-induced skin toxicity.